Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Sheppard

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|June 27, 2014
An update on the surgical management of pterygium and the role of loteprednol etabonate ointmentJohn D Sheppard, Arnulfo Mansur, Timothy L Comstock, et al.
Ophthalmology and Therapy|May 16, 2018
In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in RabbitsJohn D Sheppard, Paul C Cockrum, Angela Justice, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 28, 2024
Pooled results from two pivotal randomized controlled clinical trials: ESSENCE-1 and ESSENCE-2 to assess efficacy and safety of a water-free ciclosporin 0.1% formulation for the treatment of dry eye diseaseThomas Kaercher, John D Sheppard, Adam Hamm, et al.
Biochimica Et Biophysica Acta|October 13, 2006
Alpha,beta-dicarbonyl reduction by Saccharomyces D-arabinose dehydrogenaseBarry van Bergen, Rona Strasser, Normand Cyr, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 26, 2012
Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implantJohn D Sheppard, Quan Dong Nguyen, Dale W Usner, et al.
Ophthalmology|October 7, 2014
Antibiotic resistance in acute postoperative endophthalmitisEdward J Holland, Marguerite B McDonald, Jai G Parekh, et al.
Journal of Cataract and Refractive Surgery|February 9, 2024
Efficacy of a new water-free topical cyclosporine 0.1% solution for optimizing the ocular surface in patients with dry eye and cataractEsen K Akpek, John D Sheppard, Adam Hamm, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 12, 2022
Reproxalap Improves Signs and Symptoms of Allergic Conjunctivitis in an Allergen Chamber: A Real-World Model of Allergen ExposureDavid Clark, Paul Karpecki, Anne Marie Salapatek, et al.
American Journal of Ophthalmology|March 22, 2023
NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE StudyJohn D Sheppard, Fred Kurata, Alice T Epitropoulos, et al.
Biotechnology Progress|June 4, 2005
Comparison of PCR-DGGE and selective plating methods for monitoring the dynamics of a mixed culture population in synthetic brewery wastewaterKawai Tam, Ching-Hong Yang, Mark R Matsumoto, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Clinical Ophthalmology (Auckland, N.Z.)|June 27, 2014
An update on the surgical management of pterygium and the role of loteprednol etabonate ointmentJohn D Sheppard, Arnulfo Mansur, Timothy L Comstock, et al.
Ophthalmology and Therapy|May 16, 2018
In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in RabbitsJohn D Sheppard, Paul C Cockrum, Angela Justice, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 28, 2024
Pooled results from two pivotal randomized controlled clinical trials: ESSENCE-1 and ESSENCE-2 to assess efficacy and safety of a water-free ciclosporin 0.1% formulation for the treatment of dry eye diseaseThomas Kaercher, John D Sheppard, Adam Hamm, et al.
Biochimica Et Biophysica Acta|October 13, 2006
Alpha,beta-dicarbonyl reduction by Saccharomyces D-arabinose dehydrogenaseBarry van Bergen, Rona Strasser, Normand Cyr, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 26, 2012
Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implantJohn D Sheppard, Quan Dong Nguyen, Dale W Usner, et al.
Ophthalmology|October 7, 2014
Antibiotic resistance in acute postoperative endophthalmitisEdward J Holland, Marguerite B McDonald, Jai G Parekh, et al.
Journal of Cataract and Refractive Surgery|February 9, 2024
Efficacy of a new water-free topical cyclosporine 0.1% solution for optimizing the ocular surface in patients with dry eye and cataractEsen K Akpek, John D Sheppard, Adam Hamm, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 12, 2022
Reproxalap Improves Signs and Symptoms of Allergic Conjunctivitis in an Allergen Chamber: A Real-World Model of Allergen ExposureDavid Clark, Paul Karpecki, Anne Marie Salapatek, et al.
American Journal of Ophthalmology|March 22, 2023
NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE StudyJohn D Sheppard, Fred Kurata, Alice T Epitropoulos, et al.
Biotechnology Progress|June 4, 2005
Comparison of PCR-DGGE and selective plating methods for monitoring the dynamics of a mixed culture population in synthetic brewery wastewaterKawai Tam, Ching-Hong Yang, Mark R Matsumoto, et al.
Pageof 6